Food News and Research

RSS

Weight regain in U.S. adults who experienced substantial weight loss

Every so often, another study comes out depicting the average American as an incorrigible yo-yo dieter and committed couch potato; however, nearly six in 10 people maintained their weight loss to within 5 percent over a year's time in a new study from the Centers for Disease Control and Prevention.

8 Jun 2007

Drug giant accused of using stand-over tactics about Avandia

The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.

7 Jun 2007

Singapore too finds poison Chinese toothpaste

Singapore is the latest country to question China's food safety standards after Chinese-made toothpaste was found to contain diethylene glycol, or DEG, a poisonous chemical used in solvents and anti-freeze.

7 Jun 2007

Hypothyroidism linked to mood swings

Hypothyroidism is often associated with mood changes like depression lethargy.

5 Jun 2007

Vorinostat shows anti-cancer activity in recurrent gliomas

North Central Cancer Treatment Group (NCCTG) researchers, based at Mayo Clinic in Rochester, Minn., report that a novel application of the drug vorinostat shows activity in patients with recurrent glioblastoma multiforme.

5 Jun 2007

Study finds lymphoma drug effective over long term

Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had not had a relapse of their disease, according to researchers from the University of Michigan Comprehensive Cancer Center.

5 Jun 2007

Circulating tumor cells predict how prostate cancer patients do with chemotherapy

The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.

5 Jun 2007

Chromium picolinate and biotin combo improves blood sugar control in people with type 2 diabetes

Nutrition 21, Inc. (NASDAQ: NXXI) today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).

5 Jun 2007

Arsenic trioxide shows survival benefit for leukemia patients

Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide ,marketed as Trisenox, significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.

5 Jun 2007

Gabapentin reduces hot flashes in men receiving androgen deprivation therapy

North Central Cancer Treatment Group ( http://ncctg/ ) researchers based at Mayo Clinic ( http://www.mayo.edu/ ) in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.

5 Jun 2007

Flaxseed halts prostate tumor growth

Flaxseed, an edible seed that is rich in omega 3-fatty acids and fiber-related compounds known as lignans, is effective in halting prostate tumor growth, according to a study led by Duke University Medical Center researchers.

5 Jun 2007

FDA approves glucose monitoring system

The U.S. Food and Drug Administration today approved a device that measures glucose levels continuously for up to seven days in people with diabetes.

5 Jun 2007

New FDA committee to address risk communication

The U.S. Food and Drug Administration (FDA) today announced a new advisory committee designed to counsel the agency on how to strengthen the communication of risks and benefits of FDA-regulated products to the public.

5 Jun 2007

E/Tablet technology may improve healthcare

The old wooden clipboard and pen that patients typically encounter when providing information in a doctor's office may soon be replaced by wireless, handheld notebook-and-pen-style computers called E/Tablets.

5 Jun 2007

Dasatinib shows promise as first treatment for chronic myelogenous leukemia

An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.

5 Jun 2007